Ponto, K. A.; Schuppan, D.; Zwiener, I. et al.
Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunityCLINICAL AND EXPERIMENTAL IMMUNOLOGY. Bd. 178. H. 1. 2014 S. 57-64
Rey, Johannes Wilhelm; Jahn-Eimermacher, Antje; Doernberger, Veronika et al.
To Biopsy or Not to Biopsy: Evaluation of a Large German Cohort of Patients with Abnormal Liver Tests of Unknown EtiologyDIGESTION. Bd. 89. H. 4. 2014 S. 310-318
Goetz, M.; Walther, U.; Malek, N. et al.
Transpapillary Retrieval of a Proximally Migrated Stent Using a Three-prong Polyp Retrieval Device in a 2-years-old GirlZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 52. H. 4. 2014 S. 351-353
Thomaidis, Thomas; Woerns, Marcus A.; Galle, Peter R. et al.
Treatment of Malignant Ascites with a Second Cycle of Catumaxomab in Gastric Signet Cell Carcinoma - a Report of 2 CasesONCOLOGY RESEARCH AND TREATMENT. Bd. 37. H. 11. 2014 S. 674-677
Weinmann, Arndt; Koch, Sandra; Niederle, Ina M. et al.
Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009 An Analysis of 1066 Cases of a German HCC RegistryJOURNAL OF CLINICAL GASTROENTEROLOGY. Bd. 48. H. 3. 2014 S. 279-289
Nguyen-Tat, M.; Hoffman, A.; Marquardt, J. U. et al.
Upper Gastrointestinal Bleeding and Haemorrhagic Shock at the End of the Holidays: Pre-Hospital and In-Hospital Management of a Gastrointestinal EmergencyZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 52. H. 5. 2014 S. 441-446
Thomaidis, Thomas; Maderer, Annett; Al-Batran, Salah-Eddin et al.
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)BMC CANCER. Bd. 14. 2014
Grammatikos, Georgios; Lange, Christian; Susser, Simone et al.
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected PatientsPLOS ONE. Bd. 9. H. 2. 2014
Wedemeyer, Heiner; Yurdaydin, Cihan; Ernst, Stefanie et al.
96 weeks of pegylated-Interferon- alpha-2 alpha plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 studyHEPATOLOGY. Bd. 58. 2013 S. 222A-223A
Holzhueter, J.; Roesch, T.; Block, A. et al.
A 44-year-old woman with hereditary nonpolyposis colon carcinoma. Screening examinations for non-colonic tumorsINTERNIST. Bd. 54. H. 3. 2013 S. 353-+